Why the study?
Oligometastatic cardiac liposarcoma is rarely reported and poses a unique management challenge because oligometastatic sarcomas are typically managed with surgical resection.
Population
A 62-year-old man with oligometastatic myxoid liposarcoma to the heart
Comparison
Chemotherapy and radiotherapy without surgical management
Design
Case report and literature review
Follow-up
More than 10 years
Authors
Loading...
Rare delayed cardiac MLPS metastasis warrants vigilance in long-term survivors; leaves open optimal management strategies.
Aggressive management with chemotherapy and radiotherapy can provide long-term clinical benefit for chemosensitive and radiosensitive cardiac sarcomas when surgical removal is high-risk.
Stergiopoulos et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: